ARTICLE | Clinical News
ELI-202: Pivotal trial started
May 26, 2014 7:00 AM UTC
Elite began an open-label, two-way crossover, U.S. pivotal bioequivalence trial to compare a single dose of ELI-202 vs. an undisclosed reference drug in 32 healthy volunteers. Elite said the trial wil...